The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution
Dorzolamide Hydrochloride and Timolol Maleate · DORZOLAMIDE HYDROCHLORIDE 22.3 mg/mL; TIMOLOL MALEATE 6.8 mg/mL · Solution/ Drops · Ophthalmic · Bryant Ranch Prepack
NDC 72162-2381-02 · 1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for dorzolamide hydrochloride and timolol maleate (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA204777
- TE code
- AT1
- Approval date
- May 28, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Dorzolamide Hydrochloride and Timolol Maleate (Solution/ Drops)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Thea Pharma Inc. | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | DORZOLAMIDE HYDROCHLORIDE 22.3 mg/mL; TIMOLOL MALEATE 6.8 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Ingenus Pharmaceuticals, LLC | DORZOLAMIDE HYDROCHLORIDE 20 mg/mL; TIMOLOL MALEATE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | DORZOLAMIDE HYDROCHLORIDE 22.3 mg/mL; TIMOLOL MALEATE 6.8 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution — NDC 72162-2381-02," retrieved September 3, 2026, https://drugdashboards.com/drug/72162238102.
Free to cite with attribution — see how the data is put together.